Authors: Baselga, J Albanell, J Molina, MA Arribas, J

Citation: J. Baselga et al., Mechanism of action of trastuzumab and scientific update, SEMIN ONCOL, 28(5), 2001, pp. 4-11

Authors: Molina, MA Codony-Servat, J Albanell, J Rojo, F Arribas, J Baselga, J

Citation: Ma. Molina et al., Trastuzumab (Herceptin), a humanized anti-HER2 receptor monoclonal antibody, inhibits basal and activated HER2 ectodomain cleavage in breast cancer cells, CANCER RES, 61(12), 2001, pp. 4744-4749

Authors: Molina, MA Gimenez, MJ Gimenez, F Ramos, JA Avivar, C

Citation: Ma. Molina et al., Massive deep venous thrombosis, congenital interruption of the inferior vena cava and heterozygosity for factor V Leiden, THROMB HAEM, 84(6), 2000, pp. 1121-1122

Authors: Marino-Buslje, C Venhudova, G Molina, MA Oliva, B Jorba, X Canals, F Aviles, FX Querol, E

Citation: C. Marino-buslje et al., Contribution of C-tail residues of potato carboxypeptidase inhibitor to the binding to carboxypeptidase A - A mutagenesis analysis, EUR J BIOCH, 267(5), 2000, pp. 1502-1509

Authors: Molina, MA Sitja-Arnau, M Lemoine, MG Frazier, ML Sinicrope, FA

Citation: Ma. Molina et al., Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs, CANCER RES, 59(17), 1999, pp. 4356-4362

Authors: Mas, JM Aloy, P Marti-Renom, MA Oliva, B Blanco-Aparicio, C Molina, MA de Llorens, R Querol, E Aviles, FX

Citation: Jm. Mas et al., Protein similarities beyond disulphide bridge topology, J MOL BIOL, 284(3), 1998, pp. 541-548